1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Genitourinary Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Indication
6.1 Prostate Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovarian Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Bladder Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cervical Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Renal Cancer
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Erectile Dysfunction
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Urinary Tract Infections
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Urinary Incontinence and Overactive Bladder
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Sexually Transmitted Diseases
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Interstitial Cystitis
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Hematuria
6.11.1 Market Trends
6.11.2 Market Forecast
6.12 Benign Prostatic Hyperplasia
6.12.1 Market Trends
6.12.2 Market Forecast

7 Market Breakup by Product
7.1 Urological
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hormonal Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Gynecological
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-infectives
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast

9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Allergan plc (AbbVie Inc.)
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 SWOT Analysis
13.3.2 Antares Pharma Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.3 AstraZeneca plc
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.4 Bayer AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Bristol-Myers Squibb Company
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Genentech Inc. (Roche Holding AG)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 SWOT Analysis
13.3.7 GlaxoSmithKline plc
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Merck & Co. Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Teva Pharmaceutical Industries Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials

List of Figures
Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2021
Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2021
Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2021
Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2021
Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis

List of Tables
Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 5: Global: Genitourinary Drugs Market: Competitive Structure
Table 6: Global: Genitourinary Drugs Market: Key Players